Drug Cos. Tell 3rd Circuit To Affirm Eye Drop Suit Dismissal

On Wednesday, September 21st, Walsh Pizzi clients, Pfizer, Inc., Valeant Pharmaceuticals International, Bausch & Lomb, Inc., and Aton Pharma, Inc., along with others urged the Third Circuit not to revive the litigation accusing them of boosting prescription eye drop sales by using bottles that dispensed bigger-than-needed drops, contending that a lower court correctly found the patients didn’t show sufficient injury. The full article is available here.

For more information about the firm’s Class Action Defense practice, please contact Liza M.Walsh at (973)757-1101 or [email protected]